Skip to main content
  • Saved

made a Post

Cost-effectiveness of transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis of intermediate surgical risk in Singapore - BMC Health Services Research

Cost-effectiveness of transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis of intermediate surgical risk in Singapore - BMC Health Services Research

Source :

https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-022-08369-5

Objective The objective was to assess the cost-effectiveness of transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis with intermediate surgical risk in Singapore. Methods A de novo Markov model with three health states - stroke with long-term sequelae, no stroke, and death - was developed and simulated using Monte Carlo simulations with 10,000 iterations over a five-year time horizon from the Singapore healthcare system perspective.



Conclusion: TAVI is unlikely to be cost-effective in intermediate surgical-risk patients compared to SAVR in Singapore.